# Biomarkers of Cognitive Impairment in Blood Cells

> **NCT05582941** · — · COMPLETED · sponsor: **University of the Balearic Islands** · enrollment: 48 (actual)

## Conditions studied

- Mild Cognitive Impairment Due to Alzheimer's Disease
- Dementia Due to Alzheimer's Disease (Disorder)

## Interventions

- **OTHER:** No intervention will be performed.

## Key facts

- **NCT ID:** NCT05582941
- **Lead sponsor:** University of the Balearic Islands
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-04-01
- **Primary completion:** 2023-05-31
- **Final completion:** 2023-05-31
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2025-07-04

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05582941

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05582941, "Biomarkers of Cognitive Impairment in Blood Cells". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05582941. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*